Back
  1. Home
  2. Profile of Charlotte Rogien (UMONS)
Profil

Rogien Charlotte

UMONS - University of Mons [BE] > faculté de médecine et pharmacie > chimie générale, organique et biomédicale

Main Referenced Co-authors
BURTEA, Carmen  (1)
Feudjio Tagny, Danièle  (1)
JOURNE, Fabrice  (1)
KAHVECIOGLU, Zehra Cagla  (1)
LAURENT, Sophie  (1)
Rogien, C (1)
Main Referenced Keywords
anaplastic thyroid carcinoma (1); apoptosis (1); phage display (1); PI3K/AKT/mTOR pathway (1); therapeutic peptide (1);
Main Referenced Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (1)
Main Referenced Disciplines
Endocrinology, metabolism & nutrition (1)
Oncology (1)
Pharmacy, pharmacology & toxicology (1)
Anatomy (cytology, histology, embryology...) & physiology (1)
Biochemistry, biophysics & molecular biology (1)

Publications (total 1)

The most downloaded
1 downloads
Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Rogien, C., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (11 September 2022). Novel therapeutic strategy targeting the EGFR and inhibiting PI3K/AKT/mTOR pathway in anaplastic thyroid carcinoma [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium. https://hdl.handle.net/20.500.12907/44443

Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Rogien, C., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (11 September 2022). Novel therapeutic strategy targeting the EGFR and inhibiting PI3K/AKT/mTOR pathway in anaplastic thyroid carcinoma [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium.
Peer reviewed

Contact ORBi UMONS